secwatch.observer — SEC 8-K summary
======================================

Issuer:     Valion Bio, Inc. (VBIO)
CIK:        0001787740
Form:       8-K
Filed at:   2025-12-11T23:59:59+00:00
Accession:  0001683168-25-009079
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.90
Item codes: 1.01, 5.03, 1.02, 2.01, 2.03, 3.02, 3.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud

Tivic Health acquires Scorpius CDMO assets and closes $16.25M note and $12M preferred offerings
--------------------------------------------------------------------------------

- Acquired Scorpius CDMO assets for $16.25M cash via Article 9 sale through subsidiary Velocity Bioworks.
- Issued $16.25M senior secured convertible note to 3i, with 5% interest and 5-year maturity, to fund the acquisition.
- Sold 12,000 Series C preferred shares at $1,000 each for $12M in initial tranche; potential total up to $75M.
- Terminated $25M equity purchase agreement with Mast Hill Fund on December 9, 2025.
- Amended April 2025 purchase agreement with 3i to extend termination and lower floor price to $0.39.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787740/000168316825009079/0001683168-25-009079-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787740/000168316825009079/tivic_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-009079

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer